Table 3.
ruPAR | HASM | HBEC | BEAS2B | THP1 | PMN | PBMC | Predicted variants | |
70 | 70 | dimer/aggregates | ||||||
50–60 | 60 | 60 | 55–60 | 60 | 60 | 60 | full length | |
anti-D1 | (55-50) | 50 | (50) | alternative ex7b | ||||
(IIIF10) (kDa) | 45 | (45) | single exon deletion (e.g. exon 3 or 6) | |||||
(37) | (37) | 37 | 37 | 37 | two exon deletions (e.g. exon 5+6) | |||
30 | (30) | alternative ex7b, exon 4+5deletion | ||||||
75 | (75) | (75) | 75 | 75 | dimer/aggregates | |||
anti-D2 | 50–55 | 60 | (60) | 60 | 60 | 50 | full length | |
(3932) (kDa) |
45 | 45 | 45 | 45 | 45 | 45 | single exon deletion or alternative ex7b | |
(40) | 40 | 40 | two exon deletions | |||||
(37) | 37 | (37) | 37 | 37 | 37 | alternative ex7b, exon 4+5deletion or D2/3 fragment |
Western blots were performed using two antibodies specific to domains 1 and 2 of the uPAR protein respectively (Figure 9). The main proteins observed in each cell or tissue type with each antibody are summarised. Approximate molecular weights of bands are shown (kDa), with weaker bands shown in brackets and the strongest band in bold. Potential splice variants for each molecular weight are also shown.